Engels B, De Paoli A, Delmastro E, Munoz F, Vagge S, Norkus D
Cancers (Basel). 2023; 15(15).
PMID: 37568685
PMC: 10416952.
DOI: 10.3390/cancers15153869.
Mege D, de Chaisemartin C, Regis-Marigny L, Poizat F, Meillat H, Zemmour C
Surg Endosc. 2023; 37(7):5226-5235.
PMID: 36952048
DOI: 10.1007/s00464-021-08982-1.
Scabini S, Romairone E, Pertile D, Massobrio A, Aprile A, Tagliafico L
Diagnostics (Basel). 2022; 12(7).
PMID: 35885477
PMC: 9319737.
DOI: 10.3390/diagnostics12071571.
Giuratrabocchetta S, Formisano G, Salaj A, Opocher E, Ferraro L, Toti F
J Pers Med. 2021; 11(9).
PMID: 34575677
PMC: 8472541.
DOI: 10.3390/jpm11090900.
Martin-Gonzalez P, de Mariscal E, Martino M, Gordaliza P, Peligros I, Carreras J
PLoS One. 2020; 15(11):e0242597.
PMID: 33253194
PMC: 7704000.
DOI: 10.1371/journal.pone.0242597.
International evaluation of circumferential resection margins after rectal cancer resection: insights from the Swedish and Dutch audits.
Detering R, Saraste D, de Neree Tot Babberich M, Dekker J, Wouters M, van Geloven A
Colorectal Dis. 2019; 22(4):416-429.
PMID: 31696599
PMC: 7187294.
DOI: 10.1111/codi.14903.
Analysis of Hormone Receptor Status in Primary and Recurrent Breast Cancer Via Data Mining Pathology Reports.
Chang K, Chu Y, Wang J
Open Med (Wars). 2019; 14:91-98.
PMID: 30847396
PMC: 6401490.
DOI: 10.1515/med-2019-0013.
Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study.
Okuyama T, Sameshima S, Takeshita E, Yoshioka R, Yamagata Y, Ono Y
World J Surg Oncol. 2018; 16(1):105.
PMID: 29871650
PMC: 5989356.
DOI: 10.1186/s12957-018-1403-9.
Role of "Second Look" Lymph Node Search in Harvesting Optimal Number of Lymph Nodes for Staging of Colorectal Carcinoma.
Hamza A, Sakhi R, Khawar S, Alrajjal A, Edens J, Khurram M
Gastroenterol Res Pract. 2018; 2018:1985031.
PMID: 29805441
PMC: 5902050.
DOI: 10.1155/2018/1985031.
The quality of total mesorectal excision specimen: A review of its macroscopic assessment and prognostic significance.
Song S, Wu G, Pan H, Yang H, Hu M, Li Q
Chronic Dis Transl Med. 2018; 4(1):51-58.
PMID: 29756123
PMC: 5938287.
DOI: 10.1016/j.cdtm.2018.02.002.
Minimally Invasive Surgery for Rectal Cancer: Current Status and Future Perspectives.
Cheong C, Kim N
Indian J Surg Oncol. 2017; 8(4):591-599.
PMID: 29203993
PMC: 5705499.
DOI: 10.1007/s13193-017-0624-7.
The feasibility of laparoscopic rectal resection in patients undergoing reoperation after transanal endoscopic microsurgery (TEM).
Ortenzi M, Ghiselli R, Paolucci A, Guerrieri M
Surg Endosc. 2017; 32(4):2020-2025.
PMID: 29052070
DOI: 10.1007/s00464-017-5898-x.
Pathologic assessment of gastrointestinal tract and pancreatic carcinoma after neoadjuvant therapy.
Pai R, Pai R
Mod Pathol. 2017; 31(1):4-23.
PMID: 28776577
DOI: 10.1038/modpathol.2017.87.
The safety and effectiveness of robot-assisted versus laparoscopic TME in patients with rectal cancer: A meta-analysis and systematic review.
Li X, Wang T, Yao L, Hu L, Jin P, Guo T
Medicine (Baltimore). 2017; 96(29):e7585.
PMID: 28723798
PMC: 5521938.
DOI: 10.1097/MD.0000000000007585.
[Pathology of the R1 classification in visceral cancer surgery].
Pollheimer M, Langner C
Chirurg. 2017; 88(9):731-739.
PMID: 28593347
DOI: 10.1007/s00104-017-0448-6.
The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Nitta T, Nakamura T, Mitsuhashi T, Asano T, Okamura K, Tsuchikawa T
Surg Today. 2016; 47(4):490-497.
PMID: 27677294
DOI: 10.1007/s00595-016-1420-7.
A Review of the Long-Term Oncologic Outcomes of Robotic Surgery Versus Laparoscopic Surgery for Colorectal Cancer.
Wilder F, Burnett A, Oliver J, Demyen M, Chokshi R
Indian J Surg. 2016; 78(3):214-9.
PMID: 27358517
PMC: 4907910.
DOI: 10.1007/s12262-015-1375-8.
Robotic versus laparoscopic total mesorectal excision for rectal cancer: a meta-analysis of eight studies.
Xiong B, Ma L, Huang W, Zhao Q, Cheng Y, Liu J
J Gastrointest Surg. 2014; 19(3):516-26.
PMID: 25394387
DOI: 10.1007/s11605-014-2697-8.
Clinical significance of VEGFR-2 and ¹⁸F-FDG PET/CT SUVmax pretreatment score in predicting the long-term outcome of patients with locally advanced rectal cancer treated with neoadjuvant therapy.
Sole C, Calvo F, Alvarez E, Peligros I, Garcia-Alfonso P, Ferrer C
Eur J Nucl Med Mol Imaging. 2013; 40(11):1635-44.
PMID: 23801169
DOI: 10.1007/s00259-013-2479-7.
¹⁸F-FDG PET/CT-based treatment response evaluation in locally advanced rectal cancer: a prospective validation of long-term outcomes.
Calvo F, Sole C, De la Mata D, Cabezon L, Gomez-Espi M, Alvarez E
Eur J Nucl Med Mol Imaging. 2013; 40(5):657-67.
PMID: 23436067
DOI: 10.1007/s00259-013-2341-y.